-
The Promise of CAR T Cell Therapy in 2019 and Beyond
Dr. Michel Sadelain discusses what’s next in CAR T cell therapy, including the remarkable benefits and the…
-
CICON19 Preview: Translating Science into Survival
Topics at the upcoming CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (CICON19) in Paris include prevention, the tumor microenvironment,…
-
How Immunotherapy Is Making an Impact in Ovarian Cancer
We spoke with Dmitriy Zamarin, MD, PhD, about the current treatment landscape for patients with ovarian cancer,…
-
How Immunotherapy Is Making an Impact in Prostate Cancer
We spoke with Sumit K. Subudhi, MD, PhD, about the current treatment landscape for patients with prostate…
-
Behind the Changing Landscape of Chordoma Research and Treatment with Joan Levy, PhD
Dr. Joan Levy, director of research at the Chordoma Foundation, discusses the current state of chordoma research…
-
How Immunotherapy Is Making an Impact in Breast Cancer
We spoke with Rebecca A. Shatsky, MD, about the current treatment landscape for patients with breast cancer,…
-
CRI Hosts Academic and Industry Experts for “Immuno-Oncology: A Future Look”
CRI hosted its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media on June…
-
ASCO19 Recap: Caring for Every Patient, Learning from Every Patient
ASCO19 highlighted a number of immunotherapy developments, including those relating to long-term survival, introducing immunotherapy earlier, biomarkers,…
-
ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News
The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…
